Alzheimer's groups call for Medicare to cover controversial drugs
At issue are the medications aducanumab and lecanemab, which have both received \
Source: tennessean.com
Stay updated with breaking news from Amy Lagrant. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
At issue are the medications aducanumab and lecanemab, which have both received \
There are more than 350,000 people in Tennessee acting as caregivers to someone with Alzheimer's or Dementia. Many of them are just taking care of a family member.